Research by Family Doctors Clarifies Optimal Timing for Blood Pressure Medication

New research from the University of Alberta confirms that the timing of blood pressure medication—morning or bedtime—does not impact its effectiveness, offering greater flexibility for patients managing hypertension.
A groundbreaking study led by researchers from the University of Alberta has resolved a long-standing debate regarding the most effective time of day to take blood pressure medication. The research emphasizes that, contrary to previous suggestions, taking antihypertensive drugs in the morning or at bedtime yields similar health outcomes, offering patients more flexibility in managing their condition.
The investigation, part of the BedMed and BedMed Frail studies published in JAMA and JAMA Network Open, involved over 3,300 patients across Canada and examined whether medication timing influenced risks of heart attack, stroke, or death. Contrary to earlier Spanish studies indicating a significant benefit to evening dosing, these new results suggest that the timing does not affect the efficacy of high blood pressure treatments.
This research was prompted by findings in 2010, which reported a 61% reduction in cardiovascular events when medications were taken at night. However, subsequent studies, including a British trial, showed no differences based on timing, leading to ongoing uncertainty.
Professor Scott Garrison, the principal investigator, explains that the study’s findings provide crucial guidance, empowering patients to choose when they take their medication without fearing increased risks. Garrison highlights the importance of medication adherence and consistency over timing.
The study also included frail elderly individuals in continuing care facilities, demonstrating that medication timing did not impact fall risks or cognitive decline in this vulnerable group. Since most blood pressure naturally drops at night, concerns about bedtime dosing causing adverse effects were unfounded in this research.
This large-scale, pragmatic trial is notable for involving primary care physicians who play a critical role in real-world patient management. Garrison notes the unique engagement of family physicians in Canada, making the study highly relevant to everyday clinical practice.
Further research continues to explore other questions in primary care, such as optimal blood pressure levels in specific populations and reducing medication burdens for elderly patients, aiming to refine treatment approaches and improve patient outcomes.
Overall, these findings underscore that the most important factor in hypertension management is regular medication use, rather than specific dosing times, simplifying treatment routines and supporting patient autonomy.
Source: https://medicalxpress.com/news/2025-05-family-doctors-medication-dosage-critical.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Caregivers Express Greater Satisfaction with Specialized Dementia Care Programs Compared to Standard Care
A recent study finds that caregivers of dementia patients are more satisfied with specialized care programs than with usual care, highlighting the importance of caregiver experience in dementia support strategies.
New Biomarkers in Gut Microbiome May Predict 'Invisible' Chronic Fatigue and Long COVID
Innovative research identifies hidden biomarkers in the gut microbiome that could revolutionize diagnosis and treatment of chronic fatigue syndrome and long COVID, offering hope for personalized care based on gut health insights.
US Dementia Incidence Declines But Prevalence Continues to Rise Amid Population Aging
A recent study reveals that while new US dementia cases have declined since 2015, the number of people living with dementia continues to grow due to population aging, with significant disparities among different communities.



